You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
During July 10-13, 2011, 68 participants from 32 countries gathered in Istanbul, Turkey for a workshop organized by the United States National Research Council on Anticipating Biosecurity Challenges of the Global Expansion of High-containment Biological Laboratories. The United States Department of State's Biosecurity Engagement Program sponsored the workshop, which was held in partnership with the Turkish Academy of Sciences. The international workshop examined biosafety and biosecurity issues related to the design, construction, maintenance, and operation of high-containment biological laboratories- equivalent to United States Centers for Disease Control and Prevention biological safety le...
This first volume of a two-volume set describes general aspects, such as the historical view on the topic, the role of information distribution and preparedness of health-care systems and preparedness in emergency cases. Part two describes and discusseses in detail the pathogens and toxins that are potentially used for biological attacks. As such, the book is a valuable resource for faculties engaged in molecular biology, genetic engineering, neurology, biodefense, biosafety & biosecurity, virology, and infectious disease programs, as well as professional medical research organizations.
Public Health Surveillance (PHS) is of primary importance in this era of emerging health threats like Ebola, MERS-CoV, influenza, natural and man-made disasters, and non-communicable diseases. Transforming Public Health Surveillance is a forward-looking, topical, and up-to-date overview of the issues and solutions facing PHS. It describes the realities of the gaps and impediments to efficient and effective PHS, while presenting a vision for its possibilities and promises in the 21st century. The book gives a roadmap to the goal of public health information being available, when it is needed and where it is needed. Led by Professor Scott McNabb, a leader in the field, an international team of...
This book gathers and builds on research into distinct national and regional traditions in regulating innovation. It is an early attempt at a comprehensive legal history of the uneven trans-Atlantic harmonization of IP law. Authors explore harmonization as a legal mandate and a progressive ideal, and imagine areas in which coherent regulatory webs could build a more vibrant trans-Atlantic knowledge economy.
Biological Threats in the 21st Century offers a fresh understanding of contemporary biological threats to national security. Readers are introduced to the politics, people, science and historical roots of contemporary biological threats through up-to-date, rigorous and accessible chapters written by leading academics and supplemented by expert point-of-view contributions and interviews.The book provides inspiration and resources for students and researchers, as well as policy makers in government, the public policy sector and the wider community. It is particularly pertinent for those interested in biological disarmament, non-proliferation, counterterrorism and health security.
USA Today, Wall Street Journal, and Publishers Weekly National Bestseller “An eloquent, charismatic, and knowledgeable [critique] of a corrupt system.”—Robert F. Kennedy, Jr., from the foreword “Dr. Mercola is a visionary, pioneer, and leader.”—Del Bigtree, host of The Highwire Multiple New York Times best-selling author Dr. Joseph Mercola and Ronnie Cummins, founder and director of the Organic Consumers Association, team up to expose the truth—and end the madness—about COVID-19. Through vigorous research, over 500 references to peer-reviewed scientific journal articles, official government statistics, and public health research findings from around the world, the authors lay...
Over the past two decades bioscience facilities worldwide have experienced multiple safety and security incidents, including many notable incidents at so-called "sophisticated facilities" in North America and Western Europe. This demonstrates that a system based solely on biosafety levels and security regulations may not be sufficient. Setting the stage for a substantively different approach for managing the risks of working with biological agents in laboratories, Laboratory Biorisk Management: Biosafety and Biosecurity introduces the concept of biorisk management—a new paradigm that encompasses both laboratory biosafety and biosecurity. The book also provides laboratory managers and direc...
H1N1 ("swine flu"), SARS, mad cow disease, and HIV/AIDS are a few examples of zoonotic diseases-diseases transmitted between humans and animals. Zoonotic diseases are a growing concern given multiple factors: their often novel and unpredictable nature, their ability to emerge anywhere and spread rapidly around the globe, and their major economic toll on several disparate industries. Infectious disease surveillance systems are used to detect this threat to human and animal health. By systematically collecting data on the occurrence of infectious diseases in humans and animals, investigators can track the spread of disease and provide an early warning to human and animal health officials, nati...
This guidance is an update of WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics, published March 2005 (WHO/CDS/CSR/GIP/2005.5).
Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.